TOG Review (RCOG Journal)

MRCOG Part 2

Antenatal Care

Non-trophoblastic tumours of the placenta

Key Statistics

  • ~1% — Placentas with chorioangioma (microscopic)
  • 1 in 3500–9000 — Births with ‘giant’ (>4cm) chorioangioma
  • 8.2% — IUFD risk, expectant chorioangioma (95%CI 3.8–15.0%)

Don't-miss facts

  1. Chorioangioma: ~1% of placentas; ‘giant’ (>4cm) in 1 in 3500–9000 births – complications mainly with tumours >4cm

  2. Severe fetal anaemia = MCA PSV >1.50 MoM; polyhydramnios is the commonest complication (14–28%)

  3. Avascular appearance on colour Doppler does NOT exclude chorioangioma diagnosis

  4. Expectant IUFD risk 8.2% vs 23.6% after in-utero intervention (higher-risk cases selected for intervention)

  5. All in-utero chorioangioma intervention should occur in a specialist fetal medicine centre with MDT/patient consensus

  6. PMD vs GTD: βhCG usually normal in PMD; karyotype PMD = 46,XX/XY, partial mole = triploid – avoid erroneous termination

  7. Teratoma vs fetus acardius amorphus: look for a rudimentary umbilical cord and axial skeletal organisation (present only in amorphus)

  8. Placental metastasis carries 81% maternal mortality; melanoma, lung and gastric cancer are the commonest primaries

Tumour comparison at a glance

Chorioangioma – commonest, most complications if >4cm

Teratoma, leiomyoma, hepatocellular adenoma – rare, usually incidental/benign course PMD – 1/3 FGR, 1/3 IUFD risk, mimics GTD

Abbreviation Key

  • PMD — placental mesenchymal dysplasia
  • HELLP — haemolysis, elevated liver enzymes, low platelets
  • GTD — gestational trophoblastic disease
  • MDT — multidisciplinary team
  • FGR — fetal growth restriction
  • EMCS/ELCS — emergency/elective caesarean section
  • IUFD — intrauterine fetal death
  • NVD — normal vaginal delivery
  • MCA PSV — middle cerebral artery peak systolic velocity
  • TOP — termination of pregnancy
  • MoM — multiples of the median
  • 3D — three-dimensional
  • AFP — alpha fetoprotein
  • MRI — magnetic resonance imaging
  • βhCG — beta human chorionic gonadotropin
  • SSFSE — single-shot fast spin-echo sequence

Source: Le Vance J, Gurney L, Hodgetts Morton V. Non-trophoblastic tumours of the placenta: pathophysiology, diagnosis and management. The Obstetrician & Gynaecologist 2025;27:91–103. doi:10.1111/tog.12970

MRCOG AI is an independent educational tool. It is not affiliated with, endorsed by, or connected to the Royal College of Obstetricians and Gynaecologists (RCOG).

Included with a Pass Package

  • Audio overview of this guideline
  • Practice questions drawn from it
  • AI tutor answers grounded in its text
  • Your own annotations
Start free